4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-21-004458
CBO & COO sold 25,000 shares at an average $215.20 ($5,379,940)
- CBO & COO acquired 25,010 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klein Lawrence Otto CBO & COO | 2021-01-15 | Option exercise | +8,666 | $12.57 | $108,932 | 28,666 | D |
| Klein Lawrence Otto CBO & COO | 2021-01-15 | Sale | −2,911 | $211.44 | $615,502 | 25,755 | D |
| Klein Lawrence Otto CBO & COO | 2021-01-15 | Sale | −2,555 | $212.54 | $543,040 | 23,200 | D |
| Klein Lawrence Otto CBO & COO | 2021-01-15 | Sale | −1,200 | $213.71 | $256,452 | 22,000 | D |
| Klein Lawrence Otto CBO & COO | 2021-01-15 | Sale | −1,400 | $214.46 | $300,244 | 20,600 | D |
| Klein Lawrence Otto CBO & COO | 2021-01-15 | Sale | −400 | $216.24 | $86,496 | 20,200 | D |
| Klein Lawrence Otto CBO & COO | 2021-01-15 | Sale | −200 | $217.45 | $43,490 | 20,000 | D |
| Klein Lawrence Otto CBO & COO | 2021-01-15 | Option exercise | +16,344 | $14.43 | $235,844 | 36,334 | D |
| Klein Lawrence Otto CBO & COO | 2021-01-15 | Sale | −634 | $212.20 | $134,535 | 35,700 | D |
| Klein Lawrence Otto CBO & COO | 2021-01-15 | Sale | −2,800 | $213.64 | $598,192 | 32,900 | D |
| Klein Lawrence Otto CBO & COO | 2021-01-15 | Sale | −700 | $214.60 | $150,220 | 32,200 | D |
| Klein Lawrence Otto CBO & COO | 2021-01-15 | Sale | −1,500 | $216.39 | $324,585 | 30,700 | D |
| Klein Lawrence Otto CBO & COO | 2021-01-15 | Sale | −9,997 | $217.42 | $2,173,548 | 20,703 | D |
| Klein Lawrence Otto CBO & COO | 2021-01-15 | Sale | −701 | $218.54 | $153,197 | 20,002 | D |
| Klein Lawrence Otto CBO & COO | 2021-01-15 | Sale | −2 | $219.99 | $440 | 20,000 | D |
| Derivatives | |||||||
| Klein Lawrence Otto CBO & COO | 2021-01-15 | Option exercise · Stock Option (Right to Buy) | −8,666 | 0 | D | ||
| Klein Lawrence Otto CBO & COO | 2021-01-15 | Option exercise · Stock Option (Right to Buy) | −16,334 | 14,666 | D | ||
| Open-market sales · 25,000 sh · avg $215.20 · $5,379,940 | |||||||
Loading xslF345X03/doc4.xml…